# Céline Callens

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/celine-callens/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,048 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 37 |
| i10-index | 66 |
| Last Known Institution | Université Paris Sciences et Lettres |
| OpenAlex ID | https://openalex.org/A5027696743 |
| ORCID iD | 0000-0003-3377-4937 |
| Works | 217 |

## Researcher papers

- [SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)](https://scholariq.org/papers/sars-cov-2-infection-rates-of-antibody-positive-compared-with-antibody-negative/)
- [Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/switch-to-fulvestrant-and-palbociclib-versus-no-switch-in-advanced-breast-cancer/)
- [Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types](https://scholariq.org/papers/circulating-tumor-dna-as-a-non-invasive-substitute-to-metastasis-biopsy-for/)
- [Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia](https://scholariq.org/papers/targeting-iron-homeostasis-induces-cellular-differentiation-and-synergizes-with/)
- [Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer](https://scholariq.org/papers/letrozole-and-palbociclib-versus-chemotherapy-as-neoadjuvant-therapy-of-high/)
- [Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study](https://scholariq.org/papers/enteropathy-associated-t-cell-lymphoma-in-celiac-disease-a-large-retrospective/)
- [A mitotic transcriptional switch in polycystic kidney disease](https://scholariq.org/papers/a-mitotic-transcriptional-switch-in-polycystic-kidney-disease/)
- [Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group](https://scholariq.org/papers/prognostic-implication-of-flt3-and-ras-gene-mutations-in-patients-with-acute/)
- [Clinical Impact of <i>NOTCH1</i> and/or <i>FBXW7</i> Mutations, <i>FLASH</i> Deletion, and <i>TCR</i> Status in Pediatric T-Cell Lymphoblastic Lymphoma](https://scholariq.org/papers/clinical-impact-of-i-notch1-i-and-or-i-fbxw7-i-mutations-i-flash-i-deletion-and/)
- [ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics](https://scholariq.org/papers/erbb3-mutations-in-cancer-biological-aspects-prevalence-and-therapeutics/)
- [Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study](https://scholariq.org/papers/resistance-mechanisms-to-osimertinib-in-egfr-mutated-advanced-non-small-cell/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [Université Paris Sciences et Lettres](https://scholariq.org/institutions/universite-paris-sciences-et-lettres/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.